Key details
Collaborators
Horizon 2020 - European Commission, Novo Nordisk A/S
Enrollment target
~6,500 participants
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
30 Years – 75 Years
Last updated September 2022